“Pharmacovigilance is the science of collecting, monitoring, researching, assessing and evaluating information from healthcare providers and patients on the adverse effects of medicines, biological products, herbals and traditional medicines with a view to identify information about potential new hazards and prevent harm to patients.” Source: World Health Organization, 2002.

Talking about Medicines is also talking about risks:

  • Risks due to conditions that are unique to each human being, risks inherent to the medicine itself or to its quality.
  • Risks caused by misusing medicines.
  • Risks that go beyond representing just a possibility of occurrence have become direct causes of adverse events associated to the use of medicines that have caused human casualties.

Pharmacovigilance is an effective strategy for facilitating the intervention and contribution to the efficient, safe, and economic use of medicines, associated to, among other aspects, the detection, prevention, and settling of problems associated to medication.

“Any noxious, unintended and undesired effect of a drug, which occurs at doses used in humans for prophylaxis, diagnosis, therapy, or the modification of a physiological function.”


  1. Monitoring of scientific literature to detect alerts or news on any restriction, suspension, or prohibition imposed by the competent authorities of Mexico in order to report it to the medical community.
  2. Continuous evaluation of the risk-benefit relationship of medicines used in the hospital to prevent adverse reactions to medicines.
  3. Notify authorities about any suspected adverse reaction to medicines.
  4. Prospective monitoring of the pharmacotherapy of hospitalized patients, working to optimize the use of medicine, prevent and detect problems related to medicine and pharmacotherapeutic interventions with their subsequent registration and assessment.